Cancer Research UK Tests Therapy for Advanced Ovarian, Other Cancers in Phase 1 Trial

Cancer Research UK Tests Therapy for Advanced Ovarian, Other Cancers in Phase 1 Trial
An investigational therapy called LY3143921 hydrate will be tested for the first time in a large Phase 1 clinical trial for patients with advanced cancers, including ovarian cancer. The trial (NCT03096054) will be conducted at four centers in the United Kingdom under the supervision of the Cancer Research UK (CRUK) Centre for Drug Development (CDD).

Knowledge is power when living with ovarian cancer.

Get access to the web’s leading Ovarian Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *